Assessment of accessory pathway and atrial refractoriness by transoesophageal and intracardiac atrial stimulation - An analysis of methodological agreement
K. Nanthakumar et al., Assessment of accessory pathway and atrial refractoriness by transoesophageal and intracardiac atrial stimulation - An analysis of methodological agreement, EUROPACE, 1(1), 1999, pp. 55-62
Aims Measurement of the refractory properties of asymptomatic overt accesso
ry pathways is performed to assess the risk for significant arrhythmias. We
hypothesized that a transoesophageal atrial stimulation (TAS) protocol wou
ld accurately predict simultaneously measured invasive intra cardiac stimul
ation (ICS) of the anterograde effective refractory period of the accessory
pathway (AP-ERP)
Methods and Results Fourteen single pathway Wolff-Parkinson-White (WPW) syn
drome patients underwent TAS during ICS and 24 h prior to it. The AP-ERP wa
s measured using incremental atrial extra stimuli from TAS, the right atriu
m (RA) and the coronary sinus (CS) using drive trains of 500 and 600 ms. St
imulus latency was measured from intracardiac electrocardiograms. For metho
dological comparison, Altman-Bland analysis was used to create the limits o
f agreement (within-patient mean of differences +/- two standard deviations
). There were no or small differences in the AP-ERP, as assessed by TAS, co
mpared to RA and CS. Methodological disagreement between the three sites we
re common, however, and the limits of agreement ranged from +/- 30 to +/- 7
6 ms. The concordance between TAS and RA, with regards to the AP-ERP value
of 270 ms, was 63% when measured as S1S2 and was 67% when measured as A1A2.
The stimulation site delay was significantly shorter for TAS compared to R
A and CS sites. The two TAS procedures performed a day apart, revealed a co
efficient of variation of 9% and a coefficient of reproducibility of 63 ms.
Conclusions Despite adequate reproducibility, TAS fails to predict the AP-E
RP by ICS. Differences in stimulus latency is responsible, in part, for the
disagreement. Invasive ICS cannot be replaced by TAS for risk stratifying
WPW patients.